FABP4 and cardiomyopathy: Given these associations, we speculated that A-FABP correlates with greater BMI and may directly reflect the burden of visceral adiposity (e.g., EAT) as a marker of excessive EAT, and higher A-FABP likely plays an adjunctive pathophysiological role in mediating EAT-related “cardiomyopathy” (Figure 3).